How is the Cue Biopharma Inc today?

The Cue Biopharma Inc today is trading in the green, up by 11.67% at 0.67.

What is Cue Biopharma Inc Annual Revenue?

Cue Biopharma Inc Annual Revenue rose 69.16%, in the last year to $9.29 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Cue Biopharma Inc Annual Net Profit?

Cue Biopharma Inc Annual Net Profit rose 19.83% in the last year to $40.67 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Cue Biopharma Inc Price to Earning Ratio?

Cue Biopharma Inc Price to Earning Ratio is -1.24, which is negative.

What is Cue Biopharma Inc Stock Price?

Cue Biopharma Inc Stock Price fell 64.36% and underperformed its sector by 75.49% in the past year.

What is Cue Biopharma Inc Quarterly Revenue?

Cue Biopharma Inc Quarterly Revenue fell 75.48% YoY to $0.42 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Cue Biopharma Inc Quarterly Net profit?

Cue Biopharma Inc Quarterly Net profit rose 0.73% YoY to $12.26 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Cue Biopharma Inc Debt to Equity Ratio?

Cue Biopharma Inc Debt to Equity Ratio of 0.51 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Cue Biopharma Inc Return on Equity(ROE)?

Cue Biopharma Inc Return on Equity(ROE) for the last financial year was -149.03%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Cue Biopharma Inc Mutual Fund Holding?

Cue Biopharma Inc Mutual Fund Holding decreased by 0.6% in the last quarter to 8.04.

What is Cue Biopharma Inc Promoter Share Holding?

Cue Biopharma Inc Promoter Share Holding stayed the same in the most recent quarter at 1.05%.

What is Cue Biopharma Inc Interest Coverage Ratio?

Cue Biopharma Inc Interest Coverage Ratio is -50.1, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Cue Biopharma Inc Institutional Holding?

Cue Biopharma Inc Institutional Holding decreased by 0.64% in the last quarter to 15.26.

Cue Biopharma Inc XNAS: CUE

Cue Biopharma Inc Live Share Price Today, Share Analysis and Chart

Name: Cue Biopharma Inc: Is Infosys Ltd. worth buying?
Item: Cue Biopharma Inc
Rating: 0.95133325
Author: Trendlyne DVM scores

about

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its...

0.67 0.07 (11.67%)

66.33% Fall from 52W High

376.9K XNAS Volume

High volume+gain today

XNAS 22 May, 2025 3:03 PM (EDT)

Not Eligible

-

Expensive Valuation

14.3 / 100

Technically Bearish

23.7 / 100

3

1Yr Price target upside is 397%

3 analysts

Cue Biopharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cue Biopharma Inc FAQ

How is Cue Biopharma Inc today?

Cue Biopharma Inc today is trading in the green, and is up by 11.67% at 0.67.

How has Cue Biopharma Inc performed historically?

Cue Biopharma Inc is currently trading up 11.67% on an intraday basis. In the past week the stock fell -9.46%. stock has been down -49.24% in the past quarter and fell -64.36% in the past year. You can view this in the overview section.